Our grants and awards support clinical and translational cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young investigators to senior researchers providing mentorship opportunities for the next generation of cancer researchers. For inquiries regarding Conquer Cancer funding opportunities, please contact email@example.com.
The Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) in Medulloblastoma provides funding to promising investigators to encourage and promote quality clinical research in medulloblastoma. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. The Conquer Cancer Foundation welcomes application submissions only from investigators who are committed to conducting clinical and translational medulloblastoma research.
The CancerLinQ Discovery® Research Support Grant is a new grant that aims to inform ASCO about the impact of its guidelines, quality measures, and educational programs, and help generate the evidence necessary to support its policy and advocacy priorities. The grant support will provide access, as well as training from ASCO mentors, to conduct research on CancerLinQ Discovery® for early- and mid-career clinical oncology and health service researchers to facilitate the adoption, use, and dissemination of real-world evidence in support of ASCO’s mission.
The Conquer Cancer Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. “Global oncology” is a term that generally refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world. For purposes of this Request for Proposals (RFP), “global health” is described as an “area for study, research, and practice that places a priority on improving health and achieving health equity for all people worldwide."
The Advanced Clinical Research Award (ACRA) is a topic-specific competition designed to support physician-scientists committed to performing original, clinical cancer research in an area not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. The ACRA is a three-year grant totaling $450,000 to pay for personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting.
The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.
The Endowed Young Investigator Award (YIA) in Mantle Cell Lymphoma (MCL) provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus in MCL. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.
The Global Oncology Young Investigator Award (YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. Global oncology refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.
The International Development and Education Award (IDEA) provides support for early-career oncologists in low- and middle-income countries and facilitates the sharing of knowledge between these oncologists and ASCO members. The program pairs IDEA Recipients with a leading ASCO member “Mentor”, enables Recipients to attend the ASCO Annual Meeting, participate in a post-Meeting visit to their Mentor’s institution, and develop long-term relationships to improve cancer care in their countries. In addition, IDEA Recipients will also receive three years of complimentary ASCO membership, including a subscription to the Journal of Clinical Oncology.
In addition, the International Development and Education Award in Palliative Care (IDEA-PC) provides medical education in palliative care, assists with career development, and helps establish strong relationships with leading ASCO members in the field of palliative care who serve as scientific Mentors to each recipient. IDEA-PC Recipients are expected to share the knowledge and training they receive through the program with colleagues in their home countries once they return.
The International Innovation Grant provides research funding in support of novel and innovative projects that can have a significant impact on cancer control in low- and middle-income countries (LMCs). It is intended to support proposals that have the potential to reduce the cancer burden in local communities, while also being potentially transferable to other low- or middle-income settings.
The Long-term International Fellowship (LIFe) provides early-career oncologists in low- to middle-income countries (LMCs) the support and resources needed to advance their training by deepening their relationship with a mentor in the United States, Canada, or European Union. During the one-year fellowship, the recipients receive valuable training and experience, which they use to effect change in cancer care in their home country.
The Medical Student Rotation (MSR) provides financial support for U.S. medical students from populations underrepresented in medicine and who are interested in oncology as a career to experience a minimum 4-week clinical or clinical research rotation. The oncology rotation can take place in a private practice, hospital or academic setting, with a focus on either direct patient care or research, provided that the research is clinically-oriented.
Based on funding availability, a limited number of Merit Awards will be awarded to fellows/oncology trainees whose research is addressed in high-quality abstracts submitted to an ASCO Meeting and recognized for its scientific merit.
Merit Award recipients are honored with the opportunity to present their abstract at the Meeting, receive $1,000 in monetary support, complimentary registration for the Meeting, and access to reserved Meeting hotel reservation blocks. Merit Award candidates must apply for this award at the time of abstract submission.
This program is OPEN year-round, and due dates are determined by ASCO meeting abstract submission deadlines.
Upcoming Abstract Submission Deadlines:
- 2018 Palliative and Supportive Care in Oncology Symposium: July 24, 2018, at 11:59 PM EDT
- 2019 Gastrointestinal Cancers Symposium: September 25, 2018, at 11:59 PM EDT
- 2019 Genitourinary Cancers Symposium: October 23, 2018, at 11:59 PM EDT
- 2019 ASCO-SITC Clinical Immuno-Oncology Symposium: November 6, 2018 at 11:59 PM EST
- 2019 ASCO Annual Meeting: February 12, 2019 at 11:59 PM EST
The Research Professorship provides funding to full professors who have made significant contributions to cancer research and are dedicated to mentoring the next generation of researchers.
The Resident Travel Award (RTA) provides financial support for residents from underrepresented populations to attend the ASCO Annual Meeting. This award allows physician residents interested in a career in oncology to travel to the ASCO Annual Meeting, where they will have the opportunity to meet oncologists and to learn more about career option in the field of oncology.
These awards recognize extraordinary female leaders in oncology and role models who have excelled as a mentor and have demonstrated outstanding commitment to the professional development of women colleagues as clinicians, educators, and researchers in oncology. The awards seek to recognize and promote the work of women mentors in oncology and, ultimately, narrow career gender disparities through the mentorship and professional development of women oncology professionals. The award recipients are required to attend the Annual Meeting and will receive support to attend the meeting.
The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.